Ventana Medical Systems Acquires Shares in Vision Systems Limited

  
    
  
  
    
      Ventana Medical Systems, Inc. (NASDAQ: VMSI) today announced that it has 
      filed a Substantial Shareholder Notice with Vision Systems Limited (ASX: 
      VSL) as required under the Australian Corporations Act following Ventana’s 
      acquisition on the open market of approximately 22 million shares, or 
      10.2% of the total outstanding shares on a fully diluted basis, of 
      Vision Systems Limited (ASX: VSL) at an average price of A$2.85 per 
      share.
    
    
      About Ventana Medical Systems, Inc.
    
    
      Ventana Medical Systems develops, manufactures, and markets 
      instrument/reagent systems that automate slide preparation and staining 
      in anatomical pathology and drug discovery laboratories worldwide. 
      Ventana’s clinical systems are important tools 
      used in the diagnosis and treatment of cancer and infectious diseases. 
      Ventana’s drug discovery systems are used to 
      accelerate the discovery of new drug targets and evaluate the safety of 
      new drug compounds. Visit the Ventana Medical Systems, Inc., website at http://www.ventanamed.com.
    
  
Ventana Medical Systems, Inc. (NASDAQ: VMSI) today announced that
it has filed a Substantial Shareholder Notice with Vision Systems
Limited (ASX: VSL) as required under the Australian Corporations Act
following Ventana's acquisition on the open market of approximately 22
million shares, or 10.2% of the total outstanding shares on a fully
diluted basis, of Vision Systems Limited (ASX: VSL) at an average
price of A$2.85 per share.

   About Ventana Medical Systems, Inc.

   Ventana Medical Systems develops, manufactures, and markets
instrument/reagent systems that automate slide preparation and
staining in anatomical pathology and drug discovery laboratories
worldwide. Ventana's clinical systems are important tools used in the
diagnosis and treatment of cancer and infectious diseases. Ventana's
drug discovery systems are used to accelerate the discovery of new
drug targets and evaluate the safety of new drug compounds. Visit the
Ventana Medical Systems, Inc., website at http://www.ventanamed.com.